Volume 46, Issue 10 pp. 2686-2694
Original Article

Antibodies to high-density lipoprotein and β2-glycoprotein I are inversely correlated with paraoxonase activity in systemic lupus erythematosus and primary antiphospholipid syndrome

J. Delgado Alves

Corresponding Author

J. Delgado Alves

University College of London, London, UK

Windeyer Institute of Medical Sciences, Room 118—Centre for Rheumatology, 46 Cleveland Street, London W1T 4JF, UKSearch for more papers by this author
P. R. J. Ames

P. R. J. Ames

Whittington Hospital, London, UK

Search for more papers by this author
S. Donohue

S. Donohue

University College of London, London, UK

Search for more papers by this author
L. Stanyer

L. Stanyer

University College of London, London, UK

Search for more papers by this author
J. Noorouz-Zadeh

J. Noorouz-Zadeh

University College of London, London, UK

Search for more papers by this author
C. Ravirajan

C. Ravirajan

University College of London, London, UK

Search for more papers by this author
D. A. Isenberg

D. A. Isenberg

University College of London, London, UK

Search for more papers by this author
First published: 16 October 2002
Citations: 159

Abstract

Objective

To determine the prevalence of anti–high-density lipoprotein (anti-HDL) antibodies and to establish a possible relationship between anti-HDL, anticardiolipin antibodies (aCL), anti–β2-glycoprotein I (anti-β2GPI), and paraoxonase (PON) activity in patients with systemic lupus erythematosus (SLE) and primary antiphospholipid syndrome (APS).

Methods

Thirty-two patients with SLE and 36 with primary APS were enrolled in a cross-sectional study. Twenty age- and sex-matched healthy subjects were used as controls. Serum levels of IgG and IgM aCL, anti-β2GPI, and antiprothrombin antibodies and IgG anti-HDL were measured by enzyme-linked immunosorbent assay. Total cholesterol, HDL cholesterol, HDL2, and HDL3 were determined by standard enzymatic techniques. PON activity was assessed by quantification of nitrophenol formation, and total antioxidant capacity (TAC) by chemiluminescence.

Results

Levels of total HDL, HDL2, and HDL3 were reduced in patients with SLE compared with controls (mean ± SD 0.51 ± 0.3, 0.37 ± 0.3, and 0.14 ± 0.1 mmoles/liter, respectively, versus 1.42 ± 0.9, 1.01 ± 0.7, and 0.40 ± 0.2). Patients with SLE and primary APS had higher titers of anti-HDL antibodies and lower PON activity than controls. In the SLE population, PON activity was inversely correlated with IgG anti-HDL titers (r = −0.48, P = 0.005) whereas in the primary APS population, IgG anti-β2GPI was the only independent predictor of PON activity (r = −0.483, P = 0.003). In the SLE group, anti-HDL was inversely correlated with TAC (r = −0.40, P < 0.02), and PON activity was positively correlated with TAC (r = 0.43, P < 0.02).

Conclusion

IgG anti-HDL and IgG anti-β2GPI antibodies are associated with reduced PON activity in patients with SLE and primary APS. Since the physiologic role of PON is to prevent low-density lipoprotein oxidation with its attendant atherogenic effects, the reported interactions may be relevant to the development of atherosclerosis in SLE and primary APS.

The full text of this article hosted at iucr.org is unavailable due to technical difficulties.

click me